Chris Bosh's future remains uncertain. USATSI

The Miami Heat and Chris Bosh still don't have a resolution to his health situation. For the second straight year, it was discovered that Bosh had developed a blood clot around the All-Star break. Both times ended his season and threatened his career. The second time seemed less severe than the first one, maybe because Bosh and his family were more aware of what was going on with his body. But it's still a very serious matter that Bosh, his family and the Heat have to handle delicately in case it becomes a danger to his life.

Bosh wants to play though. The Heat want to be more cautious. The two sides have been disagreeing since around the playoffs on just how and when Bosh should return to the court, if at all. Barry Jackson of the Miami Herald reports that the latest issue to be resolved regarding his status is whether or not Bosh should continue taking blood thinners or eliminate them altogether. Being on blood thinners makes putting him back on the court extremely dangerous should he take an elbow or blow to his body that causes bleeding.

Bosh hopes to get back on the court by taking a newer medication that leaves his system in an 8-to 12-hour time frame, which is something the Heat could manage in a schedule for letting him play again.

With the Heat remaining non-committal about whether Chris Bosh will be cleared to play, one issue that has been discussed is whether Bosh should come off blood thinners or continue taking them, according to a person briefed on the matter. If Bosh comes off the medication this summer, there's no reason why he couldn't play. But even if he stays on the thinners, Bosh has tried to convince the Heat to allow him to play while taking a new medication that would be out of his system in 8 to 12 hours, or by game-time, thus lessening or eliminating the inherent risks of playing a contact sport while on thinners. As we reported last month, the Heat rejected that idea late this past season, angering Bosh. And it's unclear if Miami would be receptive to that now.

The health and well-being of Bosh is obviously first and foremost in this situation. You can't put him in danger that risks his life and people who get a second clot are more likely to develop another down the road. You don't want to keep going through this and have Bosh continue to be at risk from his profession. There is also a financial element to this, as well, for the Heat that they'd be foolish not to consider after making sure his health is being looked after.

If Bosh isn't allowed to return to the court for health reasons, the Heat can essentially clear his money off the books (while still paying him) that would go into effect one year after his final game played. He last played on February 9 of this year, so February of 2017 is when the Heat's cap would get that reprieve. However, should he come back and suffer another scare with a blood clot, that clock gets reset to his most recent game.

While the Heat no doubt want to make sure Bosh isn't at risk down the road, they also would like to have some flexibility in how they manage their roster moving forward. With Dwyane Wade gone and the team now circling the wagons around Hassan Whiteside and Goran Dragic, having the financial wiggle room to adjust by next summer when a solid free agency class hits the market would certainly benefit Pat Riley in reconstructing this roster.